AOD9604

AOD-9604

AOD-9604 is a modified peptide fragment of human growth hormone (HGH), specifically designed to retain the fat-reducing properties of HGH while minimizing its impact on blood sugar levels and growth-related pathways. It corresponds to the amino acid sequence 176–191 of the HGH molecule, which is responsible for lipolytic activity.

AOD-9604 works by stimulating lipolysis (fat breakdown) and inhibiting lipogenesis (fat formation), making it a targeted compound for fat metabolism and weight management research. Unlike full-length HGH, it does not significantly influence IGF-1 levels, reducing the risk of unwanted systemic effects.

This peptide has been extensively studied for its potential role in supporting fat loss, particularly in stubborn adipose tissue areas. It may also contribute to improved metabolic efficiency without affecting appetite or causing significant hormonal fluctuations.

Clinical and preclinical studies suggest that AOD-9604 can support reductions in body fat while maintaining a favorable safety profile, making it a promising compound for metabolic and obesity-related research.

---

All presented information is based on scientific publications which can be found at the end of product description below.

---

Description of AOD-9604

AOD-9604 is a synthetic peptide derived from the C-terminal region of human growth hormone. It is specifically engineered to isolate and enhance the fat-burning properties of HGH without triggering its growth-promoting effects.

Its mechanism focuses on regulating fat metabolism by activating pathways involved in lipolysis while inhibiting the accumulation of new fat. This makes it distinct from traditional growth hormone-based compounds.

---

Research Confirmed Effects

1. AOD-9604 and Fat Loss

AOD-9604 has demonstrated the ability to stimulate fat breakdown and reduce fat storage. It is widely studied for targeted fat reduction and weight management applications.

---

2. AOD-9604 and Metabolic Function

AOD-9604 may support improved metabolic efficiency without significantly affecting glucose metabolism or insulin sensitivity, distinguishing it from full-length HGH.

---

3. AOD-9604 and Body Composition

Research suggests that AOD-9604 may contribute to reductions in body fat while preserving lean tissue, supporting improved body composition.

---

Key Benefits

• Promotes fat breakdown (lipolysis)
• Inhibits fat accumulation (lipogenesis)
• Supports targeted fat loss
• Does not significantly affect IGF-1 levels
• Minimal impact on blood sugar regulation
• Focused metabolic activity

---

Application Areas

• Fat loss and weight management research
• Metabolic optimization
• Body composition studies

---

References

1. Studies on HGH fragment 176–191
2. Research on lipolysis and fat metabolism
3. Clinical investigations of AOD-9604
4. Additional peer-reviewed metabolic studies